The NFL is conducting a review of how the Philadelphia Eagles handled Jalen Hurts’ blood-clot situation after the players’ union requested an investigation, with Commissioner Roger Goodell saying the league’s chief medical officer, Dr. Allen Sills, reviewed the steps taken and confirmed that proper protocols were followed.

Hurts remains on injured reserve and is expected to miss the rest of the season due to a deep vein thrombosis in his left calf that progressed to pulmonary embolisms in his lungs.

The league downplayed concerns about international travel affecting Hurts’ condition, noting decisions about flying involve multiple factors evaluated by a panel of experts.

The review and statements were issued during the NFL’s fall meetings in New York, with the NFL and AP coverage characterizing the process and timeline.

Sills described that determining whether a patient with a blood clot can fly depends on multiple variables and expert input from both inside and outside the team.

The NFL players association contends there was no notification of an NFL investigation and has called for a full probe into Hurts’ medical care.

NFL executives disputed reports about Hurts’ wakefulness before the Oct. 11 game, clarifying that he slept several hours after returning to the hotel.

Hurts played in the Jaguars game despite medical concerns, finishing with 21 completions on 40 attempts for 220 yards, one touchdown, and no interceptions, before being ruled out for further contact.

Hurts has been a prominent figure, having been the Super Bowl MVP in the Eagles’ previous championship run and entering his sixth season as Philadelphia’s starter.

U.S. Senator Lisa Blunt Rochester sent a letter to Goodell seeking information and a briefing for her committee on health, education, labor and pensions about how Hurts’ case was handled, underscoring broader health-and-safety implications in sports.

The NFL emphasized that patient privacy limits disclosure of treatment details, while Goodell defended the overall quality of NFL medical care and cautioned against judging medical opinions without full records.

Several other notes highlight ongoing medical evaluations, transparency debates, and the broader context of Week 7 matchups and fantasy considerations surrounding the league.